2016 BIO CEO & Investor Conference

2/8/2016 - 2/9/2016


Now in its 18th year, the BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

  • Experience the largest, unbiased forum where
    institutional investors, industry analysts, and senior
    biotechnology executives shape the future investment
    landscape of the industry.
  • Hear Washington’s perspective on policy and other
    timely developments affecting the industry.
  • Evaluate fresh investment opportunities including
    compatible, complementary, and competitive
  • Learn about the hottest clinical developments and
    industry catalysts by attending the conference’s
    therapeutic workshops and business roundtables.
  • Attend fireside chats with CEOs who will share their
    recent company successes, what keeps the C-suite up
    at night, and where the industry’s leading companies are
    headed in 2016.
  • Gainaccess to BIO One-on-One Partnering™ for
    scouting potential investments and deal partners,
    optimizing your time at the event.
  • Unique platform for your company to highlight
    accomplishments and discuss upcoming milestones.
    150 companies will be chosen based on a selection
    process evaluating a company’s pipeline and
    R&D activities.
  • Get the pulse of the current and proposed investment
    trends in biotechnology.
  • Network with peers, investors, and potential partners
    attending the conference and our exclusive receptions.

George MacDougall:
gmacdougall@bio.org, 202-962-6689
Melissa Arndorfer:
marndorfer@bio.org, 202-962-9512




2016 BIO CEO & Investor Conference


February 8-9, 2016


Waldorf Astoria New York
301 Park Ave
New York, NY 10022